scispace - formally typeset
N

Nathalia A. Giese

Researcher at University Hospital Heidelberg

Publications -  161
Citations -  9312

Nathalia A. Giese is an academic researcher from University Hospital Heidelberg. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 51, co-authored 150 publications receiving 8107 citations. Previous affiliations of Nathalia A. Giese include French Institute of Health and Medical Research & Heidelberg University.

Papers
More filters
Journal ArticleDOI

Consensus guidelines for the detection of immunogenic cell death

Oliver Kepp, +81 more
- 29 Oct 2014 - 
TL;DR: Strategies conceived to detect surrogate markers of ICD in vitro and to screen large chemical libraries for putative I CD inducers are outlined, based on a high-content, high-throughput platform that was recently developed.
Journal ArticleDOI

Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.

TL;DR: The concomitant evaluation of PaCIC and PaCa‐related miRNA marker panels awaits retrospective analyses of larger cohorts, as it should allow for a highly sensitive, minimally‐invasive PaCa diagnostics.
Journal ArticleDOI

The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma

TL;DR: The activated stroma index (ASI) is a novel independent prognostic marker in PDAC in cases undergoing surgery and highlights the impact of the microenvironment in cancer progression and on patient survival.
Journal ArticleDOI

Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.

TL;DR: Once stimulated by cancer cells, PSCs remain active via an autocrine periostin loop even under radiotherapy and produce excessive extracellular matrix proteins, creating a tumor-supportive microenvironment.
Journal ArticleDOI

Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment

TL;DR: Targeted knockdown of HO-1 expression led to pronounced growth inhibition of the pancreatic cancer cells and made tumor cells significantly more sensitive to radiotherapy and chemotherapy.